RBL1 and cancer: Similar to p130 and p107, to the best of our knowledge, a significant enrichment of tumor-derived mutations inactivating Lin37 function has not been identified, even if several amplification, deletion, and mutation events could be detected in some cancer studies (www.cbioportal.org; http://cancer.sanger.ac.uk).